Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.700
+0.090 (3.45%)
Feb 19, 2026, 4:00 PM EST - Market closed
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $163.55 million as of February 19, 2026. Its market cap has increased by 81.48% in one year.
Market Cap
163.55M
Enterprise Value
54.70M
1-Year Change
81.48%
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $163.55M, a decrease of -73.55%. That is a compound annual growth rate of -24.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 158.10M | 23.70% |
| Dec 31, 2025 | 127.81M | 23.68% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | 618.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rani Therapeutics Holdings | 153.72M |
| Adagene | 153.65M |
| Elicio Therapeutics | 153.08M |
| ProQR Therapeutics | 152.75M |
| Zentalis Pharmaceuticals | 148.93M |
| Nkarta | 147.74M |
| ProMIS Neurosciences | 142.41M |
| Caribou Biosciences | 142.07M |